The Potential Association of Long Non-coding RNA (NEAT1 and MALAT1) in the Process of Epithelial-mesenchymal Transition in Periodontitis

Sponsor
Ali A Abdulkareem (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05995067
Collaborator
(none)
48
1
18.5
2.6

Study Details

Study Description

Brief Summary

Periodontitis is a polymicrobial, inflammatory condition affecting tooth-supporting tissues. It is characterized by a progressive loss of epithelial attachment and resorption of alveolar bone, which can lead to tooth loss. Epithelial-mesenchymal transition (EMT) has been proposed as a reversible process that shifts the cell phenotype from epithelial to mesenchymal-like and may be involved in the process of periodontal inflammation either completely or partially. Long non-coding RNAs (lncRNAs) are a large class of regulatory transcripts longer than 200 nucleotides lacking evident protein-coding potential. Studies have shown that lncRNA dysregulation plays key roles in human diseases, including cancer, by modulating the epithelial-mesenchymal transition (EMT). The involvement of lncRNAs markers in the pathogenesis of periodontal disease induced EMT has not been studied thoroughly and have created a gap in the knowledge.

Condition or Disease Intervention/Treatment Phase
  • Other: periodontitis challenge

Study Design

Study Type:
Observational
Actual Enrollment :
48 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
The Potential Association of Long Non-coding RNA (NEAT1 and MALAT1) in the Process of Epithelial-mesenchymal Transition in Periodontitis
Actual Study Start Date :
Feb 14, 2022
Anticipated Primary Completion Date :
Aug 1, 2023
Anticipated Study Completion Date :
Sep 1, 2023

Arms and Interventions

Arm Intervention/Treatment
control group

-healthy groups/without the condition

study group

-diseased group-/with the condition (periodontitis)

Other: periodontitis challenge
control will be compared to diseased group suffering from periodontal disease.

Outcome Measures

Primary Outcome Measures

  1. determining the relative expression of lncRNAs (NEAT1 and MALAT1) in healthy and diseased periodontal tissue. [one year]

    reverse transcription real time polymerase chain reaction

Secondary Outcome Measures

  1. determine the expression of EMT-related genes (E-cadherin, Vimentin, β-catenin, and Snail1), in healthy and diseased tissues, and their correlation with lncRNAs and clinical parameters. [one year]

    reverse transcription real time polymerase chain reaction

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients with no history of systemic disease e.g., diabetes.

  • Both males and females will be included in the study.

  • Control group: patients fit the case definition of gingival health2, and confirmed by Histopathological inflammatory cell infiltration analysis.

  • Periodontitis group: patients fit the case definition of periodontal disease referred for periodontal flap surgery (modified Widman's flap).

  • Patients radiographically confirmed with infrabony pocket eligible for periodontal flap surgery.

Exclusion Criteria:
  • Patients not willing to participate or consent.

  • Patient taking medications that affect or modify immunity (e.g., corticosteroid), for the last 3 months.

  • Patient taking NSAIDs for the last 3 months.

  • Active smoker.

Contacts and Locations

Locations

Site City State Country Postal Code
1 saif mohammed T AL Mufti Baghdad Iraq 964

Sponsors and Collaborators

  • Ali A Abdulkareem

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ali A Abdulkareem, assistant professor- department of periodontics-college of dentistry- Baghdad university, University of Baghdad
ClinicalTrials.gov Identifier:
NCT05995067
Other Study ID Numbers:
  • lncRNA in periodontal disease
First Posted:
Aug 16, 2023
Last Update Posted:
Aug 16, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 16, 2023